Release Date: 16/12/14 13:25 Summary: Appendix 3B - Performance Rights Price Sensitive: No Download Document 118.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%